Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/1999
02/11/1999WO1999006562A1 Method enabling readministration of aav vector via immunosuppression of host
02/11/1999WO1999006561A2 Chemokine receptor ccr8 dna and uses thereof
02/11/1999WO1999006560A1 Annexin binding protein
02/11/1999WO1999006559A1 Methods to identify growth differentiation factor (gdf) receptors
02/11/1999WO1999006558A1 Human longevity-assurance protein homologs
02/11/1999WO1999006557A2 Mammalian cell membrane proteins; related reagents
02/11/1999WO1999006556A1 Growth differentiation factor-16
02/11/1999WO1999006555A1 Novel human mmp-20 protein and use of the same
02/11/1999WO1999006554A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES
02/11/1999WO1999006553A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES
02/11/1999WO1999006552A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN
02/11/1999WO1999006551A2 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES
02/11/1999WO1999006550A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE
02/11/1999WO1999006549A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES
02/11/1999WO1999006548A2 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS
02/11/1999WO1999006547A2 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase
02/11/1999WO1999006546A1 Human orthologue of ngd5 protein regulated by opiod treatment
02/11/1999WO1999006545A2 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
02/11/1999WO1999006544A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same
02/11/1999WO1999006543A1 Assays for compounds which extend life span
02/11/1999WO1999006542A1 Methods for screening bacteriophage libraries
02/11/1999WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto
02/11/1999WO1999006539A1 Zggbp1, novel peptides related to bipolar affective disorder type 1, sequences and uses thereof
02/11/1999WO1999006536A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs
02/11/1999WO1999006535A1 Screening assays for g protein coupled receptor agonists and antagonists
02/11/1999WO1999006534A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization
02/11/1999WO1999006533A1 Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof
02/11/1999WO1999006445A1 Growth differentiation factor-15
02/11/1999WO1999006444A1 GROWTH DIFFERENTIATION FACTOR, Lefty-1
02/11/1999WO1999006443A1 Growth differentiation factor, lefty-2
02/11/1999WO1999006442A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt
02/11/1999WO1999006439A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM
02/11/1999WO1999006429A1 Method for stabilizing useful proteins and useful protein compositions
02/11/1999WO1999006428A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides
02/11/1999WO1999006427A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides
02/11/1999WO1999006426A1 Novel molecules of the tango-77 related protein family and uses thereof
02/11/1999WO1999006425A1 Oxidized styrenic polymers for dna binding
02/11/1999WO1999006423A1 83 human secreted proteins
02/11/1999WO1999006073A1 Method for the treatment of grafts
02/11/1999WO1999006068A2 Recombinant dimeric envelope vaccine against flaviviral infection
02/11/1999WO1999006066A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions
02/11/1999WO1999006064A1 Method for preventing and treating hearing loss using a neurturin protein product
02/11/1999WO1999006063A1 EPO PRIMARY RESPONSE GENE, EPRG3pt
02/11/1999WO1999006055A1 Polynucleotide compositions
02/11/1999WO1999006026A1 Stable particulate complexes with neutral or negative global charge of lamellar structure
02/11/1999WO1999005903A1 Germplasm and molecular markers for disease resistance in potato
02/11/1999WO1999005902A1 Transgenic plants tolerant of salinity stress
02/11/1999WO1998050556A3 Intracellular production of hepatitis c e1 and e2 truncated polypeptides
02/11/1999WO1998050532A3 A process for preparing an anti-oxidant
02/11/1999WO1998050397A3 Chimeric oligonucleotides and the use thereof
02/11/1999WO1998050057A3 Agent for enhancing the heart force
02/11/1999WO1998049324A3 Carbohydrate-deficient glycoprotein syndrome type i
02/11/1999WO1998049311A3 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
02/11/1999WO1998049275A3 Archaebacterium intein of the thermococcus fumicolans species
02/11/1999WO1998046771A3 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same, related proteases, and therapeutic uses thereof
02/11/1999WO1998035012A3 Methods and products for analyzing polymers
02/11/1999WO1998020354A3 Monitoring reactivity of thyroid peroxidase autoantibodies
02/11/1999DE19734218A1 Verfahren zur Ertragssteigerung in Pflanzen Method for increasing yield in plants
02/11/1999DE19733389A1 Mittel zur Expression und zum Nachweis eines ein HPOL-Epitop und ein Polypeptid umfassenden Fusionspolypeptids Means for expression and detection of a HPOL epitope and a polypeptide comprising the fusion polypeptide
02/11/1999DE19725803C1 HBV-gerichtete Antisense-Nukleinsäuren HBV-directed antisense nucleic acids
02/11/1999CA2633155A1 Stress tolerance and delayed senescence in plants
02/11/1999CA2338865A1 Methods for detecting binding events using multiple binding partners and muliple targets
02/11/1999CA2300380A1 Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof
02/11/1999CA2300336A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization
02/11/1999CA2299623A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs
02/11/1999CA2299620A1 Antifreeze proteins, dna and expression systems
02/11/1999CA2299615A1 Expression of antimicrobial peptide genes in plants, and their use in creating resistance to multiple plant pathogens
02/11/1999CA2299276A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides
02/11/1999CA2299256A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides
02/11/1999CA2299055A1 Novel molecules of the tango-77 related protein family and uses thereof
02/11/1999CA2299052A1 Secretion of carrier-bound proteins into the periplasm and into the extracellular space
02/11/1999CA2298885A1 Cellulose degrading enzymes of aspergillus
02/11/1999CA2298882A1 Transgenic plants using the tdc gene for crop improvement
02/11/1999CA2298852A1 83 human secreted proteins
02/11/1999CA2298843A1 Germplasm and molecular markers for disease resistance in potato
02/11/1999CA2298811A1 Method for the treatment of grafts
02/11/1999CA2298766A1 Human longevity-assurance protein homologs
02/11/1999CA2298573A1 Synaptojanin isoform
02/11/1999CA2298538A1 Recombinant dimeric envelope vaccine against flaviviral infection
02/11/1999CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto
02/11/1999CA2298102A1 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
02/11/1999CA2298062A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function
02/11/1999CA2298061A1 Polynucleotide compositions
02/11/1999CA2297747A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same
02/11/1999CA2297745A1 Oxidized styrenic polymers for dna binding
02/11/1999CA2297555A1 Collagen-peptide assay method
02/11/1999CA2297490A1 Method enabling readministration of aav vector via immunosuppression of host
02/11/1999CA2297489A1 Novel bone mineralization proteins, dna, vectors, expression systems
02/11/1999CA2297306A1 5'ests for non tissue specific secreted proteins
02/11/1999CA2297157A1 5' ests for secreted proteins expressed in testis and other tissues
02/11/1999CA2297109A1 5' ests for secreted proteins expressed in muscle and other mesodermal tissues
02/11/1999CA2297070A1 Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
02/11/1999CA2296844A1 5' ests for secreted proteins expressed in various tissues
02/11/1999CA2296809A1 5' ests for secreted proteins identified from brain tissues
02/11/1999CA2296667A1 5' ests for secreted proteins expressed in brain
02/11/1999CA2296663A1 Bacillus thuringiensis cry6-toxins with improved activity
02/11/1999CA2296398A1 5' ests for secreted proteins expressed in endoderm
02/11/1999CA2296394A1 Stable particulate complexes with neutral or negative global charge of lamellar structure
02/11/1999CA2296287A1 5' ests for secreted proteins expressed in prostate
02/11/1999CA2296038A1 Solid support with attached molecules
1 ... 3434 3435 3436 3437 3438 3439 3440 3441 3442 3443 3444 3445 3446 3447 3448 3449 3450 3451 3452 3453 3454 ... 4023